Singapore-Japan Fast Track Pitch Event

Building End-to-End & Patient-Centric Healthcare Solutions

Breakthroughs that change patients' lives

Message from Leadership

Erika Pagani,
Country Manager,
Pfizer Singapore

We are honoured to participate in the ASEAN-Japan Co-Creation Fast Track and look forward to embarking on a journey with start-ups to explore innovative solutions to transform healthcare. Every day, Pfizer colleagues are working to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. As we continue to discover breakthroughs that can change patients’ lives, we are committed to support open innovation, entrepreneurship and cross-pollination of ideas across industries and geographies.

Pfizer’s Challenge

Challenge 1 – Background & Rationale
The ongoing COVID-19 pandemic is a stark reminder of the importance of building more resilient health systems that are prepared for a wide variety of public health threats. Economies in Asia have demonstrated resilience and growth driven in large part by COVID-19 vaccination and treatment strategies; however, it is important to sustain investments in health—through prevention, treatment, and preparedness measures—to ensure healthy people and healthy economies.
Challenge 2 – Background & Rationale
Rare diseases remain largely underrepresented and underserved by healthcare systems around the world, especially in developing economies. In addition to limited disease awareness, other factors such as the lack of a thorough understanding of care outcome as well as the cost and burden to not just individual patients but society have led to under-diagnosis and mis-treatment.
Challenge 3 – Background & Rationale
The large volume and complexity of operational procedures, manuals and process documents in our purview require a deep understanding of the various structures, content, and use cases for each. Providing timely, detailed responses to colleague questions that arise, inclusive of appropriate referencing, is currently a very labour-intensive task.
Collaboration Needs
Challenge 1 - Problem Statement
How might we collaborate with healthcare professionals (public and private) and help the general public develop and sustain strong awareness of and immunity against highly infectious diseases (especially respiratory illnesses), and importantly, gain timely access to diagnosis and effective treatments?
Challenge 2 - Problem Statement
How might we apply the latest innovation to better monitor and measure the outcome of rare disease interventions; incorporate patient experience in value assessment; and support (public and private) healthcare payors’ reimbursement decisions?
Challenge 3 - Problem Statement
To partner with experts in AI/NLP who can build a digital assistant capable of answering questions on documents related to the healthcare and pharmaceutical industry. Those responses would then refer back to the content location where that automated answer was found.
  • Co-design, prototype and market-test novel solutions with Pfizer
  • Scale up across therapeutic areas and/or geographical locations
  • Access to potential longer-term strategic and commercial partnership
  • Unparalleled subject matter expertise and market knowledge
  • Designated muti-disciplinary team and time
  • Potential funding for pilot/PoC

About Pfizer

Pfizer Inc.: Breakthroughs that Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. To learn more, please visit us on